Security Snapshot

Enlivex Ltd. - Class A common stock (ENLV) Institutional Ownership

CUSIP: M4130Y106

13F Institutional Holders and Ownership History from Q1 2019 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

35

Shares (Excl. Options)

3,639,120

Price

$0.93

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+2,316,531
Value change
+$2,203,155
Number of holders
35
Issuer context Names, identifiers, and filing context for this profile. 2 identity fields
Shares outstanding
4,195,190
SEC-reported price per share
$0.67
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • ENLV - Enlivex Ltd. - Class A common stock is tracked under CUSIP M4130Y106.
  • 35 institutions reported positions in Q1 2026.
  • 1 significant owner is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 25 to 35 between Q4 2025 and Q1 2026.
  • SEC-reported value moved from $929,383 to $3,380,401.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 35 institutions filings for Q1 2026.

Open SEC evidence

Security key

M4130Y106

Latest holder period

Q1 2026

13F holders

35

13D/G owners

1

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
1
Security
ENLV
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARMISTICE CAPITAL, LLC 5% $272,142 209,340 Armistice Capital, LLC 30 Jun 2025

As of 31 Mar 2026, 35 institutional investors reported holding 3,639,120 shares of Enlivex Ltd. - Class A common stock (ENLV). This represents 87% of the company’s total 4,195,190 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
87%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Diametric Capital, LP 35% 1,483,178 0.36% $1,379,503
ARK Investment Management LLC 15% 628,310 0% $584,391
PRELUDE CAPITAL MANAGEMENT, LLC 5.4% 225,738 0.02% $209,959
TWO SIGMA INVESTMENTS, LP 3.5% 146,412 -25% 0% $136,178
UBS Group AG 3.3% 138,328 +295% 0% $128,646
BANK OF AMERICA CORP /DE/ 3.1% 130,401 +53% 0% $121,273
RENAISSANCE TECHNOLOGIES LLC 3.1% 128,192 -59% 0% $119,231
JPMORGAN CHASE & CO 3% 125,948 +5835% 0% $113,353
GOLDMAN SACHS GROUP INC 2.4% 102,093 0% $94,957
XTX Topco Ltd 2.4% 100,362 +62% 0% $93,347
MORGAN STANLEY 2.3% 98,333 -51% 0% $91,459
GEODE CAPITAL MANAGEMENT, LLC 1.9% 80,560 0% $74,928
Invesco Ltd. 1.5% 61,654 +1.2% 0% $57,344
Virtu Financial LLC 1% 43,253 -8.7% 0% $40,000
CITADEL ADVISORS LLC 0.67% 27,965 +9.3% 0% $26,010
TWO SIGMA SECURITIES, LLC 0.48% 20,044 0% $18,643
Prosperity Consulting Group, LLC 0.42% 17,647 0% 0% $16,413
HARBOUR INVESTMENTS, INC. 0.38% 16,000 0% $14,882
MILLENNIUM MANAGEMENT LLC 0.28% 11,779 0% $10,956
NEUBERGER BERMAN GROUP LLC 0.26% 10,988 0% 0% $10,220
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.25% 10,314 0% $9,593
SkyView Investment Advisors, LLC 0.24% 10,000 0% 0% $9,000
WELLS FARGO & COMPANY/MN 0.22% 9,384 +2.2% 0% $8,728
Tower Research Capital LLC (TRC) 0.07% 2,877 +29% 0% $2,676
SIMPLEX TRADING, LLC 0.06% 2,615 -71% 0% $2,432

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
29
Latest
Q1 2026
Rows shown
1-25 of 29
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 3,639,120 $3,380,401 +$2,203,155 $0.93 35
2025 Q4 1,322,589 $929,383 +$162,996 $0.70 25
2025 Q3 914,520 $950,163 -$1,876,489 $1.04 29
2025 Q2 2,562,493 $2,870,793 -$660,551 $1.12 21
2025 Q1 3,172,878 $3,077,787 -$231,383 $0.97 26
2024 Q4 3,410,246 $3,988,303 +$965,814 $1.17 24
2024 Q3 2,564,823 $4,308,904 +$807,487 $1.68 19
2024 Q2 2,084,177 $2,959,532 +$2,158,083 $1.42 16
2024 Q1 326,146 $1,236,215 +$541,301 $3.79 15
2023 Q4 188,457 $509,494 -$101,537 $2.70 17
2023 Q3 257,635 $408,820 -$97,128 $1.58 16
2023 Q2 302,487 $795,439 -$107,223 $2.63 19
2023 Q1 343,260 $1,238,359 +$17,014 $3.64 18
2022 Q4 337,460 $1,313,998 +$75,986 $3.92 19
2022 Q3 333,239 $1,412,000 -$1,410,029 $4.25 18
2022 Q2 604,532 $2,890,000 -$1,287,958 $4.52 19
2022 Q1 846,271 $4,752,000 +$1,024,486 $5.60 23
2021 Q4 662,557 $4,115,000 -$1,225,489 $6.24 20
2021 Q3 847,653 $8,382,460 -$1,349,433 $9.88 19
2021 Q2 987,814 $8,789,216 -$1,499,870 $8.90 20
2021 Q1 1,059,657 $11,730,140 +$7,345,089 $11.08 23
2020 Q4 398,346 $3,358,000 +$295,129 $8.43 11
2020 Q3 321,043 $1,906,000 -$156,743 $5.93 4
2020 Q2 355,221 $1,797,000 -$3,024,311 $5.05 7
2020 Q1 959,592 $4,493,000 +$3,963,154 $4.69 6
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .